Dean Investment Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.17M Sell
37,505
-2,457
-6% -$572K 1.29% 5
2025
Q4
$8.27M Sell
39,962
-13,954
-26% -$2.76M 1.18% 8
2025
Q3
$10M Sell
53,916
-4,892
-8% -$838K 1.4% 4
2025
Q2
$8.98M Buy
58,808
+927
+2% +$142K 1.32% 3
2025
Q1
$9.6M Buy
57,881
+5,437
+10% +$851K 1.42% 4
2024
Q4
$7.58M Sell
52,444
-3,108
-6% -$482K 1.08% 10
2024
Q3
$9M Sell
55,552
-284
-0.5% -$45.2K 1.22% 5
2024
Q2
$8.16M Sell
55,836
-2,983
-5% -$444K 1.16% 12
2024
Q1
$9.3M Sell
58,819
-601
-1% -$95.7K 1.28% 4
2023
Q4
$9.31M Sell
59,420
-2,835
-5% -$435K 1.33% 2
2023
Q3
$9.7M Sell
62,255
-285
-0.5% -$47K 1.59% 2
2023
Q2
$10.4M Sell
62,540
-314
-0.5% -$50.7K 1.69% 1
2023
Q1
$9.74M Buy
62,854
+27,934
+80% +$4.51M 1.56% 2
2022
Q4
$6.17M Buy
34,920
+3,483
+11% +$601K 1.05% 13
2022
Q3
$5.14M Buy
31,437
+501
+2% +$84.8K 1.05% 12
2022
Q2
$5.49M Sell
30,936
-702
-2% -$125K 1.07% 11
2022
Q1
$5.61M Buy
31,638
+452
+1% +$76.9K 1.01% 12
2021
Q4
$5.33M Sell
31,186
-251
-0.8% -$41.1K 0.94% 18
2021
Q3
$5.08M Buy
31,437
+5
+0% +$853 0.96% 17
2021
Q2
$5.18M Sell
31,432
-102
-0.3% -$16.9K 0.96% 15
2021
Q1
$5.18M Sell
31,534
-427
-1% -$69.1K 0.98% 9
2020
Q4
$5.03M Sell
31,961
-1,530
-5% -$226K 1.04% 6
2020
Q3
$4.99M Sell
33,491
-629
-2% -$93.1K 1.19% 7
2020
Q2
$4.8M Buy
34,120
+984
+3% +$143K 1.15% 8
2020
Q1
$4.34M Sell
33,136
-2,832
-8% -$402K 0.93% 16
2019
Q4
$5.25M Sell
35,968
-15,521
-30% -$2.11M 0.82% 30
2019
Q3
$6.66M Buy
51,489
+485
+1% +$63.9K 0.98% 12
2019
Q2
$7.1M Sell
51,004
-125
-0.2% -$17.3K 1.02% 11
2019
Q1
$7.15M Sell
51,129
-171
-0.3% -$22.9K 1.04% 14
2018
Q4
$6.62M Buy
51,300
+937
+2% +$131K 1.05% 15
2018
Q3
$6.96M Buy
50,363
+1,107
+2% +$147K 0.97% 20
2018
Q2
$5.98M Sell
49,256
-1,532
-3% -$191K 0.88% 31
2018
Q1
$6.51M Sell
50,788
-1,976
-4% -$267K 0.96% 23
2017
Q4
$7.37M Sell
52,764
-176
-0.3% -$24.5K 1.13% 9
2017
Q3
$6.88M Sell
52,940
-7,516
-12% -$996K 1.05% 16
2017
Q2
$8M Buy
60,456
+1,292
+2% +$165K 1.22% 4
2017
Q1
$7.37M Buy
59,164
+536
+0.9% +$64K 1.23% 7
2016
Q4
$6.75M Sell
58,628
-472
-0.8% -$54.5K 1.16% 10
2016
Q3
$6.98M Buy
59,100
+418
+0.7% +$50.7K 1.3% 5
2016
Q2
$7.12M Sell
58,682
-2,577
-4% -$293K 1.39% 5
2016
Q1
$6.63M Buy
61,259
+46
+0.1% +$4.76K 1.35% 5
2015
Q4
$6.29M Sell
61,213
-1,323
-2% -$133K 1.39% 5
2015
Q3
$5.84M Buy
62,536
+301
+0.5% +$29.1K 1.32% 4
2015
Q2
$6.07M Buy
62,235
+1,545
+3% +$155K 1.38% 5
2015
Q1
$6.11M Sell
60,690
-1,011
-2% -$103K 1.42% 7
2014
Q4
$6.45M Sell
61,701
-790
-1% -$83.3K 1.49% 4
2014
Q3
$6.66M Buy
62,491
+405
+0.7% +$42K 1.62% 4
2014
Q2
$6.5M Sell
62,086
-822
-1% -$83.1K 1.5% 5
2014
Q1
$6.18M Sell
62,908
-488
-0.8% -$45.2K 1.49% 9
2013
Q4
$5.81M Sell
63,396
-449
-0.7% -$41.4K 1.39% 14
2013
Q3
$5.54M Sell
63,845
-236
-0.4% -$21.2K 1.45% 7
2013
Q2
$5.5M Buy
+64,081
New +$5.44M 1.57% 7

Other funds holding JNJ

Dean Investment Associates's JNJ Position: Q1 2026 in Review

Dean Investment Associates reduced its Johnson & Johnson (JNJ) stake by 6.1% in Q1 2026, selling an estimated $572K and leaving 37,505 shares worth $9.17M. The position accounts for 1.29% of the portfolio, ranked #5.

Dean Investment Associates first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.4M in Q2 2023. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Dean Investment Associates held 37,505 shares of Johnson & Johnson worth $9.17M as of Q1 2026.
  • Dean Investment Associates sold 2,457 Johnson & Johnson shares in Q1 2026, an estimated $572K.
  • Johnson & Johnson made up 1.29% of Dean Investment Associates's portfolio in Q1 2026, its #5 holding.
  • Dean Investment Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Dean Investment Associates's Johnson & Johnson position peaked at $10.4M in Q2 2023.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Dean Investment Associates's 13F filing for Q1 2026, filed 15 May 2026.